Thyroid abnormalities in patients with extreme insulin resistance syndromes

Thyroid abnormalities in patients with extreme insulin resistance syndromes Abstract Introduction Insulin and leptin may increase growth and proliferation of thyroid cells, underlying an association between type 2 diabetes and papillary thyroid cancer (PTC). Patients with extreme insulin resistance due to lipodystrophy or insulin receptor mutations (INSR) are treated with high-dose insulin and recombinant leptin (metreleptin), which may increase risk of thyroid neoplasia. The aim of this study was to analyze thyroid structural abnormalities in patients with lipodystrophy and INSR mutation, and to assess if insulin, IGF-1, and metreleptin therapy contribute to the thyroid growth and neoplasia in this population. Materials and methods Thyroid ultrasound characteristics were analyzed in 81 patients with lipodystrophy and 11 with INSR (5 homozygous; 6 heterozygous). Sixty were taking metreleptin. Results The prevalence of thyroid nodules in children with extreme insulin resistance (5/30, 16.7%) was significantly higher than published prevalence for children (64/3202; 2%), with no difference between lipodystrophy and INSR. BSA-adjusted thyroid volume was larger in INSR homozygotes versus heterozygotes or lipodystrophy (10.4±5.1, 3.9±1.5, 6.2±3.4 cm2, respectively. Three patients with lipodystrophy and one INSR heterozygote had PTC. There were no differences in thyroid ultrasound features in patients treated versus untreated with metreleptin. Conclusion Children with extreme insulin resistance had high prevalence of thyroid nodules, which were not associated with metreleptin treatment. Patients with homozygous INSR mutation had thyromegaly, which may be a novel phenotypic feature of this disease. Further studies are needed to determine the etiology of thyroid abnormalities in patients with extreme insulin resistance. This content is only available as a PDF. Copyright © 2019 Endocrine Society http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Endocrinology and Metabolism Oxford University Press

Loading next page...
 
/lp/oxford-university-press/thyroid-abnormalities-in-patients-with-extreme-insulin-resistance-oRfSmrEX38
Publisher
Oxford University Press
Copyright
Copyright © 2019 Endocrine Society
ISSN
0021-972X
eISSN
1945-7197
D.O.I.
10.1210/jc.2018-02289
Publisher site
See Article on Publisher Site

Abstract

Abstract Introduction Insulin and leptin may increase growth and proliferation of thyroid cells, underlying an association between type 2 diabetes and papillary thyroid cancer (PTC). Patients with extreme insulin resistance due to lipodystrophy or insulin receptor mutations (INSR) are treated with high-dose insulin and recombinant leptin (metreleptin), which may increase risk of thyroid neoplasia. The aim of this study was to analyze thyroid structural abnormalities in patients with lipodystrophy and INSR mutation, and to assess if insulin, IGF-1, and metreleptin therapy contribute to the thyroid growth and neoplasia in this population. Materials and methods Thyroid ultrasound characteristics were analyzed in 81 patients with lipodystrophy and 11 with INSR (5 homozygous; 6 heterozygous). Sixty were taking metreleptin. Results The prevalence of thyroid nodules in children with extreme insulin resistance (5/30, 16.7%) was significantly higher than published prevalence for children (64/3202; 2%), with no difference between lipodystrophy and INSR. BSA-adjusted thyroid volume was larger in INSR homozygotes versus heterozygotes or lipodystrophy (10.4±5.1, 3.9±1.5, 6.2±3.4 cm2, respectively. Three patients with lipodystrophy and one INSR heterozygote had PTC. There were no differences in thyroid ultrasound features in patients treated versus untreated with metreleptin. Conclusion Children with extreme insulin resistance had high prevalence of thyroid nodules, which were not associated with metreleptin treatment. Patients with homozygous INSR mutation had thyromegaly, which may be a novel phenotypic feature of this disease. Further studies are needed to determine the etiology of thyroid abnormalities in patients with extreme insulin resistance. This content is only available as a PDF. Copyright © 2019 Endocrine Society

Journal

Journal of Clinical Endocrinology and MetabolismOxford University Press

Published: Jan 16, 2019

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off